Nothing in Medicine Makes Sense Except in the Light of Evolution: A Review

  • Bernard Swynghedauw

Abstract

Applying evolutionary biology to medical problems is surprisingly new and still absent from medical as well biological teaching, despite the fact that “nothing in biology makes sense except in the light of evolution” (T. Dobzhansky in Am. Biol. Teach. 35:125, 1973), and biology is the basis of medicine. Evolutionary medicine takes the view that contemporary diseases are related to incompatibility between the environment in which humans currently live and the conditions under which human biology evolved and genomes have been shaped by a different environment during biological evolution. Human activity has recently acutely modified the environmental conditions in which all living beings live. The main result is a spectacular increased lifespan and pronounced change in the medical landscape. The concept of evolutionary medicine applies to every disease state. From an epidemiological viewpoint, the simultaneous increased incidence in both autoimmune (type 1 diabetes, Crohn’s disease, etc.) and allergic (asthma, childhood allergy, etc.) diseases is inversely related to the drop in infectious diseases. The so-called hygiene hypothesis is now solidly established and its mechanism is well documented. It involved both a strong genetic component and a dysregulation of the immune system with a main role attributed to interleukin-10. The conflict resulting from the free availability of food and salt and the remaining fat- and salt-retaining genes is now considered as a major determinant of the rising epidemic incidence of obesity, arterial hypertension and type 2 diabetes. The so-called metabolic syndrome is a summary of these different components and represents a major goal for contemporary preventive medicine. For example, genome-wide association studies have currently identified at least nine genes which are significantly associated with type 2 diabetes. Cancer may be viewed as an accelerated form of evolution at the level of cancer cells. About one third of the hundreds of mutations which have been identified so far in cancers are subject to an evolutionary pressure with a nearly doubling of the nonsynonymous to synonymous substitutions ratio. The genome-environment relationship is a major paradigm for a biologist. It is equally important in medicine, and diseases can now be ascribed as a threshold on a norm reaction curve that depends on a given genotype.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anonymous (2007) Light at the end of the tunnel. Nature 445:567Google Scholar
  2. 2.
    Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920PubMedCrossRefGoogle Scholar
  3. 3.
    Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ (1989) Weight in infancy and death from ischemic heart disease. Lancet 2:577–580PubMedCrossRefGoogle Scholar
  4. 4.
    Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV (1998) Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 338:640–644PubMedCrossRefGoogle Scholar
  5. 5.
    Boomsma D, Bujsjahn A, Peltonen L (2002) Classical twin studies and beyond. Nat Rev Genet 3:872–882PubMedCrossRefGoogle Scholar
  6. 6.
    Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867PubMedCrossRefGoogle Scholar
  7. 7.
    Cupples LA, Arruda HT, Benjamin EJ, D’Agostino RB Sr, Demissie S, DeStefano AL, Dupuis J, Falls KM, Fox CS, Gottlieb DJ, Govindaraju DR, Guo CY, Heard-Costa NL, Hwang SJ, Kathiresan S, Kiel DP, Laramie JM, Larson MG, Levy D, Liu CY, Lunetta KL, Mailman MD, Manning AK, Meigs JB, Murabito JM, Newton-Cheh C, O’Connor GT, O’Donnell CJ, Pandey M, Seshadri S, Vasan RS, Wang ZY, Wilk JB, Wolf PA, Yang Q, Atwood LD (2007) The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet 8(Suppl I):SIGoogle Scholar
  8. 8.
    DeWitt TJ, Scheiner SM (2004) Phenotypic plasticity. Functional and conceptual approaches. Oxford University Press, New YorkGoogle Scholar
  9. 9.
    Dobzhansky T (1973) Nothing in biology makes sense except in the light of evolution. Am Biol Teach 35:125–129Google Scholar
  10. 10.
    Doughty P, Reznick DN (2004) Patterns and analysis of adaptative phenotypic plasticity in animals. In: DeWitt TJ, Scheiner SM (eds) Phenotypic plasticity. Functional and conceptual approaches. Oxford University Press, New YorkGoogle Scholar
  11. 11.
    Eaton SB, Konner M (1985) Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 312:283–289PubMedGoogle Scholar
  12. 12.
    Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415–1428PubMedCrossRefGoogle Scholar
  13. 13.
    Finkel T, Serrano M, Blasco MA (2007) The common biology of cancer and ageing. Nature 448:767–774PubMedCrossRefGoogle Scholar
  14. 14.
    Flier JS (2004). Obesity wars: molecular progress confronts an expanding epidemic. Cell 116:337–350PubMedCrossRefGoogle Scholar
  15. 15.
    Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889–892PubMedCrossRefGoogle Scholar
  16. 16.
    Greaves M (2002) Cancer causation: the Darwinian downside of past success? Lancet Oncol. 3:244–251PubMedCrossRefGoogle Scholar
  17. 17.
    Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O’Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR (2007) Patterns of somatic mutation in human cancer genomes. Nature 446:153–158PubMedCrossRefGoogle Scholar
  18. 18.
    Haines A, Kovats RS, Campbell-Lendrum D, Corvalon C (2006) Climate change and human health: impacts, vulnerability, and mitigation. Lancet 367:2101–2109PubMedCrossRefGoogle Scholar
  19. 19.
    Hales S, Woodward A (2003) Climate change will increase demands on malaria control in Africa. Lancet 363:1775CrossRefGoogle Scholar
  20. 20.
    Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70PubMedCrossRefGoogle Scholar
  21. 21.
    Hopp MJ, Foley JA (2003) Worldwide fluctuations in dengue fever cases related to climate variability. Clim Res 25:85–94CrossRefGoogle Scholar
  22. 22.
    International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320CrossRefGoogle Scholar
  23. 23.
    Jobling MA, Hurles ME, Tyler-Smith C (2004) Human evolutionary genetics. Origins, peoples and disease. Garland, New YorkGoogle Scholar
  24. 24.
    Junien C, Gallou-Kabani C, Vigé A, Gross M-S (2005) Epigénomique nutritionnelle du syndrome métabolique. Med Sci (Paris) 21:396–404Google Scholar
  25. 25.
    Le Tertre A, Lefranc A, Eilstein D, Declercq C, Medina S, Blanchard M, Chardon B, Fabre P, Filleul L, Jusot JF, Pascal L, Prouvost H, Cassadou S, Ledrans M (2006) Impact of the 2003 heatwave on all-cause mortality in 9 French cities. Epidemiology 17:75–79PubMedCrossRefGoogle Scholar
  26. 26.
    Lorincz AM, Sukumai S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13:279–292PubMedCrossRefGoogle Scholar
  27. 27.
    MacCallum CJ (2007) Does medicine without evolution make sense? PLoS Biol 5:e112–e114PubMedCrossRefGoogle Scholar
  28. 28.
    MacMichael AJ, Woodruff RE, Hales S (2006) Climate change and human health present and future risks. Lancet 367:859–869CrossRefGoogle Scholar
  29. 29.
    MacMillen C, Robinson JS (2005) Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85:571–633CrossRefGoogle Scholar
  30. 30.
    Meagher TR (2007) Is evolutionary biology strategic science? Evolution Jan 239–244Google Scholar
  31. 31.
    Medina-Ramón M, Schwartz J (2007) Temperature, temperature extremes, and mortality: a study of acclimatisation and effect modification in 50 US cities. Occup Environ Med 64:827–833. doi:10.1136/oem.2007.033175Google Scholar
  32. 32.
    Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6:924–935PubMedCrossRefGoogle Scholar
  33. 33.
    Neel JV (1962) Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet 14:353–362PubMedGoogle Scholar
  34. 34.
    Nesse RM, Williams G (1994) Why we get sick: the new science of Darwinian medicine. Times Books, New YorkGoogle Scholar
  35. 35.
    Patz JA, Olson SH (2005) Malaria risk and temperature: influences from global climate change and local land use practices. Proc Natl Acad Sci USA 103:5635–5636CrossRefGoogle Scholar
  36. 36.
    Schwartz MW, Porte D Jr (2005) Diabetes, obesity, and the brain. Science 307:375–379PubMedCrossRefGoogle Scholar
  37. 37.
    Silva JE (2006) Thermogenic mechanisms and their hormonal regulation. Physiol Rev 86:435–464PubMedCrossRefGoogle Scholar
  38. 38.
    Stearns SC (1999) Evolution in health and disease. Oxford University Press, OxfordGoogle Scholar
  39. 39.
    Swynghedauw B (2006) Phenotypic plasticity of adult myocardium. Molecular mechanisms. J Exp Biol 209:2320–2327PubMedCrossRefGoogle Scholar
  40. 40.
    Trevathan WR, Smith EO, McKenna JJ (1999) Evolutionary medicine. Oxford University Press, OxfordGoogle Scholar
  41. 41.
    van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rössner S, RIO-Europe Study Group (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365:1389–1397Google Scholar
  42. 42.
    Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRefGoogle Scholar
  43. 43.
    Wills-Karp M, Santeliz J, Karp CL (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1:69–75PubMedCrossRefGoogle Scholar
  44. 44.
    Woltereck R (1909) Weitere experimentelle Untersuchungen über Artveränderung, spezielle über das wesen quantitativer Artunterschiede bei Saphniden. Verh Dtsch Zool Ges 19:110–172Google Scholar
  45. 45.
    Wright A, Hastie N (2007) Genes and common diseases. Genetic in modern medicine. Cambridge University Press, CambridgeGoogle Scholar
  46. 46.
    Yazdanbakhsh M, Kremaner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296:490–494PubMedCrossRefGoogle Scholar
  47. 47.
    Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104:2855–2864PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Bernard Swynghedauw
    • 1
  1. 1.Hôpital LariboisièreCentre de Recherches Cardiovasculaires de 1’INSERMParis CEDEXFrance

Personalised recommendations